Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: writing on the wall

Its not that Hawk dosn't think that PTSC is a good story, but that it was not the right time to tell the story.  That is we anticipate the numbers in April to be great.  PTSC will have shown how valuable the stock is based on hard numbers.  What better time to shout the PTSC story from the roof tops to the investment world than after PTSC has shown hard numbers to back up the story.

All the best,

Steve

Share
New Message
Please login to post a reply